209 related articles for article (PubMed ID: 10446115)
41. Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection.
Ruggeri C; La Masa AT; Rudi S; Squadrito G; Di Pasquale G; Maimone S; Caccamo G; Pellegrino S; Raimondo G; Magazzù G
Dig Dis Sci; 2008 Aug; 53(8):2151-5. PubMed ID: 18231858
[TBL] [Abstract][Full Text] [Related]
42. Prevalence of antibodies to hepatitis C virus and correlation with liver disease in renal transplant patients.
Rostaing L; Izopet J; Cisterne JM; Icart J; Chabannier MH; Panicali H; Durand D
Am J Nephrol; 1997; 17(1):46-52. PubMed ID: 9057953
[TBL] [Abstract][Full Text] [Related]
43. Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma.
Lee MH; Yang HI; Lu SN; Jen CL; You SL; Wang LY; L'Italien G; Chen CJ; Yuan Y;
Int J Cancer; 2014 Sep; 135(5):1119-26. PubMed ID: 24482200
[TBL] [Abstract][Full Text] [Related]
44. HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: possibility of coinfection in these patients must be considered in HBV-high endemic area.
Lee DS; Huh K; Lee EH; Lee DH; Hong KS; Sung YC
J Gastroenterol Hepatol; 1997 Dec; 12(12):855-61. PubMed ID: 9504897
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic Dilemmas in Hepatitis C Virus Infection for Hemodialysis Patients.
Komitova RT; Atanasova MV; Pavlova TA; Nyagolov MS; Ivanova AV
Folia Med (Plovdiv); 2017 Mar; 59(1):70-77. PubMed ID: 28384106
[TBL] [Abstract][Full Text] [Related]
46. Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus-related chronic liver disease.
Fujiwara K; Tanaka Y; Orito E; Ohno T; Kato T; Sugauchi F; Suzuki S; Hattori Y; Sakurai M; Hasegawa I; Ozasa T; Kanie F; Kano H; Ueda R; Mizokami M
J Gastroenterol Hepatol; 2004 Dec; 19(12):1343-7. PubMed ID: 15610306
[TBL] [Abstract][Full Text] [Related]
47. Leukopenia and thrombocytopenia in hemodialysis patients with hepatitis B or C virus infection and non-hemodialysis patients with hepatitis cirrhosis.
Ng YY; Lin CC; Wu SC; Hwang SJ; Ho CH; Yang WC; Lee SD
Clin Nephrol; 2002 Apr; 57(4):289-95. PubMed ID: 12005245
[TBL] [Abstract][Full Text] [Related]
48. [Autoantibodies in chronic hepatitis C. Markers of autoimmunity or non-specific events?].
Vella FS; Orlando P; Attanasi F; Simone B; Mundo A; Lopalco P; Schiraldi O; Antonaci S
Recenti Prog Med; 2001 Feb; 92(2):107-12. PubMed ID: 11294098
[TBL] [Abstract][Full Text] [Related]
49. Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios.
Wolffram I; Petroff D; Bätz O; Jedrysiak K; Kramer J; Tenckhoff H; Berg T; Wiegand J;
J Hepatol; 2015 Jun; 62(6):1256-64. PubMed ID: 25617500
[TBL] [Abstract][Full Text] [Related]
50. Hepatitis C virus genotypes among patients with lichen planus in the Kingdom of Saudi Arabia.
Halawani M
Int J Dermatol; 2014 Feb; 53(2):171-7. PubMed ID: 23675675
[TBL] [Abstract][Full Text] [Related]
51. HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease.
Sagnelli E; Coppola N; Scolastico C; Mogavero AR; Filippini P; Piccinino F
J Med Virol; 2001 Jul; 64(3):350-5. PubMed ID: 11424125
[TBL] [Abstract][Full Text] [Related]
52. IgG1 and IgG4 antibodies against Core and NS3 antigens of hepatitis C virus.
Santos VCD; Schinoni MI; Oliveira IS; Atta MLS; Atta AM
Rev Soc Bras Med Trop; 2019 Mar; 52():e20180491. PubMed ID: 30843970
[TBL] [Abstract][Full Text] [Related]
53. Epidemiological relationship of oral lichen planus to hepatitis C virus in an Indian population.
Patil S; Khandelwal S; Rahman F; Kaswan S; Tipu S
Oral Health Dent Manag; 2012 Dec; 11(4):199-205. PubMed ID: 23208597
[TBL] [Abstract][Full Text] [Related]
54. Low prevalence of liver-kidney microsomal autoantibodies of type 1 (LKM1) in hepatitis C seropositive subjects on Crete, Greece.
Drygiannakis D; Lionis C; Drygiannakis I; Pappas G; Kouroumalis E
BMC Gastroenterol; 2001; 1():4. PubMed ID: 11418082
[TBL] [Abstract][Full Text] [Related]
55. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.
Nousbaum JB; Pol S; Nalpas B; Landais P; Berthelot P; Bréchot C
Ann Intern Med; 1995 Feb; 122(3):161-8. PubMed ID: 7810932
[TBL] [Abstract][Full Text] [Related]
56. Anti-HCV positive hepatocellular carcinoma in cirrhosis. Prevalence, risk factors and clinical features.
Farinati F; Fagiuoli S; De Maria N; Chiaramonte M; Aneloni V; Ongaro S; Salvagnini M; Naccarato R
J Hepatol; 1992 Mar; 14(2-3):183-7. PubMed ID: 1380021
[TBL] [Abstract][Full Text] [Related]
57. Sera of children with hepatitis C infection and anti-liver-kidney microsome-1 antibodies recognize different CYP2D6 epitopes than adults with LKM+/HCV+ sera.
Herzog D; Yamamoto AM; Jara P; Maggiore G; Sarles J; Alvarez F
J Pediatr Gastroenterol Nutr; 1999 Nov; 29(5):551-5. PubMed ID: 10554122
[TBL] [Abstract][Full Text] [Related]
58. Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance.
Fukuda R; Ishimura N; Niigaki M; Hamamoto S; Satoh S; Tanaka S; Kushiyama Y; Uchida Y; Ihihara S; Akagi S; Watanabe M; Kinoshita Y
J Med Virol; 1999 Jul; 58(3):201-7. PubMed ID: 10447413
[TBL] [Abstract][Full Text] [Related]
59. Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels.
Carreño V; Pardo M; López-Alcorocho JM; Rodríguez-Iñigo E; Bartolomé J; Castillo I
J Infect Dis; 2006 Jul; 194(1):53-60. PubMed ID: 16741882
[TBL] [Abstract][Full Text] [Related]
60. Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection.
Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
Arch Virol; 1997; 142(3):535-44. PubMed ID: 9349299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
